UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2021-04, Vol.32 (4), p.452-465

2021

Volltextzugriff (PDF)

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Supportive care in cancer, 2020-10, Vol.28 (10), p.4589-4612

2020

Volltextzugriff (PDF)

Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide

Annals of oncology, 2018-08, Vol.29 (8), p.1718-1726

2018

Volltextzugriff (PDF)

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.100-106

2016

Volltextzugriff (PDF)

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

Annals of oncology, 2023-03, Vol.34 (3), p.247-250

2023

Volltextzugriff (PDF)

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv126-iv142

2018

Volltextzugriff (PDF)

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Annals of oncology, 2014-02, Vol.25 (2), p.462-466

2014

Volltextzugriff (PDF)

Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action

Annals of oncology, 2020-10, Vol.31 (10), p.1289-1290

2020

Volltextzugriff (PDF)

The pathogenesis of mucositis: updated perspectives and emerging targets

Supportive care in cancer, 2019-10, Vol.27 (10), p.4023-4033

2019

Volltextzugriff (PDF)

Preventive action with a population of excavator drivers exposed to whole-body vibration

Work (Reading, Mass.), 2021-01, Vol.68 (2), p.473-481

2021

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Annals of oncology, 2017-10, Vol.28 (10), p.2547-2551

2017

Volltextzugriff (PDF)

De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control “always” matter?

Oral oncology, 2024-05, Vol.152, p.106768-106768, Article 106768

2024

Volltextzugriff (PDF)

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Oral oncology, 2009-07, Vol.45 (7), p.574-578

2009

Volltextzugriff (PDF)

Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study)

Oral oncology, 2024-10, Vol.157, p.106950, Article 106950

2024

Volltextzugriff (PDF)

Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

Supportive care in cancer, 2020-11, Vol.28 (11), p.5059-5073

2020

Volltextzugriff (PDF)

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

European journal of cancer (1990), 2016-12, Vol.69, p.158-165

2016

Volltextzugriff (PDF)

Management of Tyrosine Kinase Inhibitors (TKI) Side Effects in Differentiated and Medullary Thyroid Cancer Patients

Baillière's best practice & research. Clinical endocrinology & metabolism, 2017-06, Vol.31 (3), p.349-361

2017

Volltextzugriff (PDF)

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2017-11, Vol.28 (11), p.2820-2826

2017

Volltextzugriff (PDF)

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Annals of oncology, 2014-08, Vol.25 (8), p.1628-1635

2014

Volltextzugriff (PDF)

Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation

American journal of neuroradiology : AJNR, 2020-08, Vol.41 (8), p.1473-1479

2020

Volltextzugriff (PDF)

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

European journal of cancer (1990), 2018-07, Vol.97, p.7-15

2018

Volltextzugriff (PDF)

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2018-04, Vol.29 (4), p.985-991

2018

Volltextzugriff (PDF)

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Annals of oncology, 2012-07, Vol.23 (7), p.1832-1837

2012

Volltextzugriff (PDF)

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Annals of oncology, 2017-09, Vol.28 (9), p.2321-2322

2017

Volltextzugriff (PDF)

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

Head & neck, 2019-04, Vol.41 (4), p.908-914

2019

Volltextzugriff (PDF)

1 – 25 von 1.640

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.399)
Mit Volltextzugriff
(1.368)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide

Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendations

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial

Elapsed time for an unresolved adverse event: systemic anticancer therapy-induced neurotoxicity calls for action

The pathogenesis of mucositis: updated perspectives and emerging targets

Preventive action with a population of excavator drivers exposed to whole-body vibration

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control “always” matter?

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Expression of PDL-1 between primary and recurrent/metastatic head and neck squamous cell carcinoma: A bi-institutional retrospective concordance analysis (CONCORDL-1 study)

Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

Management of Tyrosine Kinase Inhibitors (TKI) Side Effects in Differentiated and Medullary Thyroid Cancer Patients

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor

Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer

Suchergebnisse filtern